CNS disorder therapeutic - Schrodinger
Latest Information Update: 16 Feb 2024
At a glance
- Originator Schrodinger
- Developer Schrodinger; Unknown
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I CNS disorders
Most Recent Events
- 16 Jan 2024 Phase-I clinical trials in CNS disorders (unspecified route), before January 2024 (Schrodinger pipeline, January 2024)